Opportunity overview
T1D-Plus trial is a randomised, adaptive, open label, parallel group, multi-centre Platform trial in adults with newly diagnosed type 1 diabetes). The T1D Plus trial, funded by JDRF, sponsored by CU, started on 30th September 2022, led by Colin Dayan. Since that time, additional arms of the trial have been funded by separate grants from the Helmsley Charitable Trust and JDRF Australia. Funding was agreed in Dec 2023. An endpoint in the trial is the recording of glucose levels by a continuous glucose monitoring device. These devices are marketed by different companies with different specifications.
Awarded to
Amounts belong to published awards or contracts. Where several suppliers share one value, it is labelled as shared and is not a supplier-specific allocation.
Dexcom International Limited
- Contract value
- £76k
- Awarded
- Not supplied
- Contract signed
- 19 Jan 2026
- Including VAT
- £91.2k
- Award ID
- 1
- Status
- active
- Location
- Edinburgh, UKM75, EH3 5DA, United Kingdom
Classification
No classification was supplied.
Lots
- Lot 1Value not stated
Documents and notices
- Contract details notice on Find a TenderOpen source ↗
- contractSignedOpen source ↗